SCHEMBL19211341

SCHEMBL19211341

Cc1ccc(OCc2cn(-c3ccc(F)c(CC(F)F)c3)nn2)nc1C

nearest known ligand 0.69

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
RXRA P19793 20/20 0.69
GRIN1 Q05586 19/20 0.69
GRIN2B Q13224 19/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19219620 0.82 RXRA (1.00) RXRAGRIN1GRIN2B
SCHEMBL19219271 0.80 RXRA (0.66) RXRAGRIN1GRIN2B
SCHEMBL19211310 0.79 RXRA (0.75) RXRAGRIN1GRIN2B
SCHEMBL19211371 0.78 GRIN1 (0.75) RXRAGRIN1GRIN2B
SCHEMBL19219294 0.77 RXRA (1.00) RXRAGRIN1GRIN2B
SCHEMBL19219260 0.73 RXRA (1.00) RXRAGRIN1GRIN2B
SCHEMBL19219496 0.73 RXRA (1.00) RXRAGRIN1GRIN2B
SCHEMBL19219262 0.72 RXRA (1.00) RXRAGRIN1GRIN2B
SCHEMBL19219545 0.72 RXRA (1.00) RXRAGRIN1GRIN2B
SCHEMBL19219163 0.71 RXRA (1.00) RXRAGRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414233-A1 SUBSTITUTED 1,2,3-TRIAZOLES AS NR2B-SELECTIVE NMDA MODULATORS Janssen Pharmaceutica NV (BE) 2018-12-19 EP claimed
WO-2017139428-A1 SUBSTITUTED 1,2,3-TRIAZOLES AS NR2B-SELECTIVE NMDA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2017-08-17 WO claimed